Skip to content

Single Use Injector NM600/610 NM-600L-0621Recalls & reported problems

Olympus Medical Systems Corp. · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04953170377594), received between Feb 2, 2023 and Feb 2, 2023 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Hemorrhage/Blood Loss/Bleeding1
  • Laceration(s)1
  • Unspecified Tissue Injury1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 2, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    OLYMPUS REVIEWED THE FOLLOWING LITERATURE TITLED "PROCEDURE-RELATED COMPLICATIONS IN GASTRIC VARICEAL OBTURATION WITH TISSUE GLUE". THE AIM OF THIS ARTICLE WAS TO FOCUS ON PROCEDURE-RELATED COMPLICATIONS, EVALUATE THEIR INCIDENCE, ANALYZE THE REASONS AND DISCUSS THE SOLUTIONS IN 519 PATIENTS. COMPLICATIONS INCLUDING STICKING OF THE NEEDLE TO THE VARIX OCCURRED IN 9 CASES (1.43%). THE NEEDLE WAS SUCCESSFULLY WITHDRAWN IN 8 CASES. LARGE SPURT BLEEDING OCCURRED IN ONE CASE, AND HEMOSTASIS WAS ACHIEVED BY TWO OTHER INJECTIONS OF UNDILUTED GLUE. THE INJECTION CATHETER BECAME BLOCKED IN 17 CASES (2.71%) JUST DURING THE INJECTION, AND 4 CASES WERE COMPLICATED WITH THE NEEDLE STICKING TO THE VARIX. LARGE GLUE ADHESION TO THE ENDOSCOPE RESULTED IN DIFFICULTY WITHDRAWING THE ENDOSCOPE IN 1 CASE. THIS STUDY CONCLUDES THAT EGVO WITH TISSUE GLUE IS USUALLY SAFE AND EFFECTIVE, A SERIES OF COMPLICATIONS CAN OCCUR DURING THE PROCEDURE THAT MAY PUZZLE ENDOSCOPISTS. TYPE OF ADVERSE EVENTS/NUMBER OF PATIENTS. STICKING OF THE NEEDLE TO THE VARIX - 9 PATIENTS. BLOCKAGE OF THE INJECTION CATHETER - 17 PATIENTS. GLUE ADHESION TO THE ENDOSCOPE RESULTED IN DIFFICULTY WITHDRAWING THE ENDOSCOPE - 1 PATIENT. L

    Patient problems: Hemorrhage/Blood Loss/Bleeding; Laceration(s); Unspecified Tissue Injury

    MAUDE report 16288203 ↗

Other endoscopic injection needle, gastroenterology-urology devices

All endoscopic injection needle, gastroenterology-urology devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page